NIH-funded research R21 grant

Creating a new mouse model to study brown fat function

Official title: A validated mouse model of brown fat targeting

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-10809155 · Data updated 2026-11-12

This study is creating a special mouse that helps scientists see and understand how brown fat works in the body, which could lead to better treatments for conditions like obesity and diabetes.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJuly 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$240,750
NIH project number1R21OD034470-01A1
Project IDNIH-10809155 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would include individuals with metabolic disorders or conditions related to obesity and energy regulation.

Less likely to help

Patients who do not have metabolic disorders or are not affected by brown fat-related conditions may not receive any benefit from this research.

What this research studies

This research focuses on developing a new mouse model that targets brown adipose tissue, which plays a crucial role in regulating metabolism and energy balance. By using advanced CRISPR/Cas9 technology, the researchers aim to insert a specific genetic marker into a safe location in the mouse genome, allowing for precise tracking of brown fat cells. This model will help scientists better understand the role of brown fat in various physiological processes and could lead to advancements in treatments for metabolic disorders. The research will also validate the new model to ensure its effectiveness and safety for broader scientific use.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for metabolic diseases related to brown fat dysfunction.

How similar studies have gone: Other research using CRISPR technology for genetic modifications in animal models has shown promising results, indicating a potential for success in this novel approach.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Sanchez-Gurmaches, Juan — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Sanchez-Gurmaches, Juan

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.